-
"Shaping the Future of Excipients" - IPEC Europe Annual Seminar"Shaping the Future of Excipients" - IPEC Europe Annual Seminar 27 January 2011, Cannes (Fr) The premier European forum on the science and regulation of pharmaceutical excipients - the IPEC Europe2010/12/1
-
Impacting the Search for New Therapies: Stem Cell Models and Drug DiscoveryInternational Drug Discovery and Thermo Scientific Present a Free Webcast on Cells. Date: Wednesday, December 8, 2010 Time: 10:00 AM EST Embryonic stem cells (ES) provide a valuable tool for b2010/11/30
-
BASF increases prices for certain polyalcohols in EuropeLudwigshafen, Germany – November 29, 2010 – BASF is increasing the prices of the polyalcohols neopentylglycol (NPG), trimethylolpropane (TMP), 1,6-hexanediol (HDO), epsilon-caprolactone (CLO), with2010/11/30
-
Pharma enhances its focus on Asia-Pacific partnershipsWhile the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre col2010/11/29
-
FDA Drug Safety Communication: FDA recommends against the continued use of propoxypheneSafety Announcement The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of the pain reliever propoxyphene because new data show that the drug can cau2010/11/29
-
The 1st Excipient Festival ChinaForum of International Drug Preparations & Pharmaceutical Excipient Development The 1st Excipient Festival China People are paying more attention to the quality and effectiveness of pha2010/11/26
-
SFDA streamlines requirements for application dossiers of imported non-special purpose cosmeticsSFDA streamlines requirements for application dossiers of imported non-special purpose cosmetics In order to further simplify the requirements for application dossiers of imported non-special purp2010/11/25
-
FDA warning leads to decrease in antidepressant prescribing for young patientsFDA warning leads to decrease in antidepressant prescribing for young patients An FDA warning regarding increased suicide risk in children and teens taking antidepressant drugs has led to an overa2010/11/25
-
FDA grants Impax tentative approval for generic Cymbalta NDAFDA grants Impax tentative approval for generic Cymbalta NDA Impax Laboratories, Inc. (NASDAQ: IPXL) today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval2010/11/24
-
Par enters distribution agreement with AstraZeneca for generic AccolatePar enters distribution agreement with AstraZeneca for generic Accolate Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has entered into an exclusive supply and distribution2010/11/24